- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04609748
Comparative Analysis of the Effectiveness of the Use of Nimesulide and CBD Oil in Patients With Pain in the Preauricular Region Due to the Pain-dysfunctional Syndrome of the Temporomandibular Joint.
During the study, the effectiveness of analgesic therapy with nimmsulide and cannabidiol oil will be compared.
Two study groups will be formed. The study will be conducted on patients reporting to the Dental Prosthetics Clinic of PUM in Szczecin. Patients aged 18-65 years with pain located in the area of the temporomandibular joint and the preauricular area, resulting from a dysfunction of the temporomandibular joint, will be included in the study.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Phase 2
Contacts and Locations
Study Contact
- Name: Kamila Szczuchniak, DMD
Study Contact Backup
- Name: Bartosz Dalewski, DMD, PhD
- Phone Number: 914661717
- Email: bartosz.dalewski@pum.edu.pl
Study Locations
-
-
-
Szczecin, Poland
- Recruiting
- Chair and Depratment of Dental Prosthetics
-
Contact:
- Bartosz Dalewski, DMD, PhD
- Email: bartosz.dalewski@pum.edu.pl
-
Sub-Investigator:
- Kamila Szczuchniak, DMD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients (female and male) aged 18-65 years, able to swallow tablets
- Patients with pain located in the temporomandibular and preauricular regions resulting from temporomandibular joint dysfunction
- Patients with clinical diagnosis of Temporomandibular Joint Dysfunction
Exclusion Criteria:
- patients with clinically diagnosed acute inflammation of the outer ear, middle ear, sinuses of the nose
- patients allergic to nimesulide or cannabidiol oil
patients with contraindications to include therapy with nimesulide or cannabidiol oil such as:
- gastric or duodenal ulcer disease,
- severe blood clotting disorders,
- severe liver dysfunction,
- severe renal impairment,
- severe heart failure, pregnancy,
- breastfeeding,
- concomitant intake of citrochrome blockers CYP3A4 or CYPP2D6 (warfarin, macrolides, calcium channel blockers, benzodiazepines, cyclosporine, sildenafil, SSRI, tricyclic antidepressants, opioids)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: The group that received nimesulide
|
Nimessulid will be given twice a day - 2x100mg, applied orally.
The therapy will last 15 days.
|
EXPERIMENTAL: The group that received CBD Oil
|
Cannabidiol oil will be given twice a day, in a dose of 33,6mg, applied orally.
The therapy will last 15 days.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain relief
Time Frame: 15 days
|
Measured on Visual Analogue Scale (VAS) scale.
It consists of a line, approximately 100mm in length, at the left end of the scale "Score 0" which means "no pain", at the right end of the scale "Score 100mm" which means "worst imaginable pain"
|
15 days
|
Psychological conditions
Time Frame: 15 days
|
Measured on The General Health Questionnaire-28 (GHQ-28)
|
15 days
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Pain
- Neurologic Manifestations
- Disease
- Musculoskeletal Diseases
- Muscular Diseases
- Stomatognathic Diseases
- Jaw Diseases
- Craniomandibular Disorders
- Mandibular Diseases
- Myofascial Pain Syndromes
- Syndrome
- Arthralgia
- Joint Diseases
- Temporomandibular Joint Disorders
- Temporomandibular Joint Dysfunction Syndrome
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Peripheral Nervous System Agents
- Enzyme Inhibitors
- Analgesics
- Sensory System Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Antirheumatic Agents
- Cyclooxygenase Inhibitors
- Anticonvulsants
- Cannabidiol
- Nimesulide
Other Study ID Numbers
- KB-0012/149/2020
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Temporomandibular Joint Disorders
-
Hacettepe UniversityThe Scientific and Technological Research Council of TurkeyRecruitingTemporomandibular Joint Disorders | Temporomandibular Joint Dysfunction Syndrome | Temporomandibular Disorder | Temporomandibular Joint Pain | Manual Therapy | Temporomandibular Joint Disc DisplacementTurkey
-
TC Erciyes UniversityRecruitingTemporomandibular Joint Disorders | Temporomandibular Disorder | Temporomandibular Joint Pain | Temporomandibular Joint Osteoarthritis | Temporomandibular Joint EffusionTurkey
-
University of Nove de JulhoUnknownTemporomandibular DisorderBrazil
-
Karolinska InstitutetUniversity of Oslo; University of BergenCompletedTemporomandibular Joint Disorders | Temporomandibular Joint Disc Displacement | Temporomandibular Joint Osteoarthritis | Temporomandibular ArthritisSweden
-
Wroclaw Medical UniversityEnrolling by invitationTemporomandibular Joint Disorders | Temporomandibular Disorder | Temporomandibular Joint Osteoarthritis | Temporomandibular ArthritisPoland
-
Hacettepe UniversityKarabuk UniversityRecruitingTemporomandibular Joint Disorders | Temporomandibular Joint Dysfunction Syndrome | Temporomandibular DisorderTurkey
-
CES UniversityCompletedTemporomandibular Disorder | Children, Only | Pain Disorder | Joint Disorder, Temporomandibular
-
University of L'AquilaUnknownTEMPOROMANDIBULAR JOINT DISEASESItaly
-
Marmara UniversityRecruitingTemporomandibular Joint Disorders | Temporomandibular DisorderTurkey
-
Yeditepe UniversityUnknownTemporomandibular Disorders, Articular Disc Disorder (Reducing or Non-Reducing) | Osteopathy in Temporomandibular DisordersTurkey
Clinical Trials on Nimesulide
-
Novartis PharmaceuticalsWithdrawnUpper Respiratory Tract Infections
-
European Institute of OncologyCompleted
-
EMSCompletedDyspepsia | Acute and Chronic InflammationBrazil
-
University of Roma La SapienzaCompletedTemporomandibular Joint Disorders
-
Dr. Reddy's Laboratories LimitedCompleted
-
Woerwag Pharma LLCCompletedAcute Non-specific Low Back PainRussian Federation